MENU
SION
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Sionna Therapeutics (SION) Earnings Date & Reports
Sionna Therapeutics Inc is a clinical-stage biopharmaceutical company on a mission to revolutionize the current treatment paradigm for cystic fibrosis (CF) patients by developing novel medicines that normalize the function of the cystic fibrosis transmembrane conductance regulator (CFTR) protein to deliver clinically meaningful benefits to CF patients... Show more
A.I. Advisor
published Earnings
SION is expected to report earnings to fall 13.33% to -51 cents per share on August 17
Q2'26
Est.
$-0.52
Q1'26
Beat
by $0.02
Q4'25
Beat
by $0.25
Q3'25
Beat
by $0.14
Q2'25
Beat
by $0.11
The last earnings report on May 12 showed earnings per share of -60 cents, beating the estimate of -62 cents. With 189.64K shares outstanding, the current market capitalization sits at 1.62B.
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information